Welcome to the Gannett Company Incorporated Q4 2024 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...